By Gregory Smith, Phil Kim and John Tilton, Sheppard Mullin Over the last five years, private equity (PE) firms have invested in excess of $450 billion in the healthcare industry – more than $250 billion of which can be accounted for in the past two years alone. This influx of capital also happens to coincide […]
The post Private equity faces heightened FCA and antitrust scrutiny appeared first on PE Hub.
Powered by WPeMatico
Comments are closed.